Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study

BACKGROUND: Information on the risk of acute pancreatitis in patients receiving dipeptidyl-peptidase IV inhibitors (DPP-4i) is limited and controversial. One study suggested that the differences in findings between these meta-analyses were attributed to whether they included large randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Gun, Kim, Seirhan, Han, Seung Jin, Kim, Dae Jung, Lee, Kwan-Woo, Kim, Hae Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914097/
https://www.ncbi.nlm.nih.gov/pubmed/29850606
http://dx.doi.org/10.1155/2018/5246976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914097/
https://www.ncbi.nlm.nih.gov/pubmed/29850606
http://dx.doi.org/10.1155/2018/5246976

Ejemplares similares